7 of 11 biosimilars approved in Korea were developed by Korean company

Published: 2017-09-07 14:01:22

Updated: 2017-09-07 14:01:22

It was reported there were the total 11 biosimilar products approved in Korea, such as ‘Remsima 100mg,’ and 7 of them were developed by Korean pharmaceutical companies.

According to the Ministry of Food and Drug Safety(MFDS), after Celltrion’s ‘Remsima 100mg’ was first approved as a biosimilar on 20 July 2012, there have been 11 biosimilar products approved so far.

The 11^th approved biosimila...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.